Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Current Opinion in Pulmonary Medicine|July 24, 2026
Advanced imaging in sarcoidosisMadia Ampey, Daniel Steinberger, David PerlmanCurrent Problems in Cancer. Case Reports|November 8, 2021
Lymphadenopathy after the third Covid-19 vaccineCan Özütemiz, David A Potter, Ayça Özbek Özütemiz, et al.BMC Cancer|June 26, 2026
Measurement of metabolic activity by telemetric temperature sensing after immunotherapy and chemotherapy on three different mouse tumor modelsSina Meisamy, Kurt Brattain, Qi Shao, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 12, 2024
Quantitative SPECT/CT Metrics in Early Prediction of [177Lu]Lu-DOTATATE Treatment Response in Gastroenteropancreatic Neuroendocrine Tumor PatientsOnur Tuncer, Daniel Steinberger, Joseph Steiner, et al.Radiology|February 24, 2021
Lymphadenopathy in COVID-19 Vaccine Recipients: Diagnostic Dilemma in Oncologic PatientsCan Özütemiz, Luke A Krystosek, An L Church, et al.Journal for Immunotherapy of Cancer|June 20, 2018
Near complete response to Pembrolizumab in microsatellite-stable metastatic sebaceous carcinomaEvidio Domingo-Musibay, Paari Murugan, Alessio Giubellino, et al.Annals of Nuclear Medicine|March 2, 2024
The active papillary muscle sign in 18F-FDG PET/CT cardiac sarcoidosis exams and its relationship with myocardial suppressionCan Özütemiz, Yasemin Koksel, Jerry W Froelich, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 27, 2021
COMPARISON OF THE EFFECT OF THREE DIFFERENT DIETARY MODIFICATIONS ON MYOCARDIAL SUPPRESSION IN 18F-FDG PET/CT EVALUATION OF PATIENTS FOR SUSPECTED CARDIAC SARCOIDOSISCan Ozutemiz, Yasemin Koksel, Jerry W Froelich, et al.Cancers|January 8, 2025
Isolation of Plasma Extracellular Vesicles for High-Depth Analysis of Proteomic Biomarkers in Metastatic Castration-Resistant Prostate Cancer PatientsAli T Arafa, Megan Ludwig, Onur Tuncer, et al.Cell Reports. Medicine|April 21, 2026
Plasma extracellular vesicle proteomics nominates candidate biomarkers of 177Lu-PSMA-617 outcomes in metastatic prostate cancer patientsAli T Arafa, Ella Boytim, Megan L Ludwig, et al.Pageof 1